Meningococcal vaccine
Meningococcal Vaccine[edit]
The Meningococcal Vaccine refers to any vaccine derived from Neisseria meningitidis, used for the prophylaxis against meningitis. These vaccines can be in whole-cell or acellular forms and are crucial in preventing meningococcal disease, a serious bacterial infection.
History of Meningococcal Vaccine[edit]
The development of meningococcal vaccines began in the 20th century, with significant advancements over the decades. The first large-scale use of a meningococcal vaccine occurred in the 1960s.
Types of Meningococcal Vaccines[edit]
There are several types of meningococcal vaccines available:
MenACWY Vaccines[edit]
MenACWY vaccines are conjugate vaccines that protect against four serogroups of Neisseria meningitidis—A, C, W, and Y. Examples include Menactra and Menveo.
MenB Vaccines[edit]
MenB vaccines, like Bexsero and Trumenba, provide protection against serogroup B meningococcal bacteria.
Usage and Administration[edit]
Meningococcal vaccines are recommended for people at increased risk for meningococcal disease, including:
- Adolescents
- Travelers to certain parts of the world
- Persons with specific medical conditions
Effectiveness and Protection[edit]
These vaccines are highly effective in preventing meningococcal disease caused by serogroups covered by the vaccine. They can significantly reduce the risk of infection.
Side Effects and Safety[edit]
Common side effects include redness and pain at the injection site. Severe allergic reactions are rare. Overall, the vaccines are considered safe and effective.
External Links[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
| This medical article is a stub. You can help WikiMD by expanding the page. |
.png){kind=link}
